Middle Eastern Penny Stocks: Gulf Pharmaceutical Industries P.S.C And Two More To Watch
Top 10 Penny Stocks In The Middle East
Name
Share Price
Market Cap
Financial Health Rating
Big Tech 50 R&D-Limited Partnership (TASE:BIGT)
₪1.414
₪15M
★★★★★★
Thob Al Aseel (SASE:4012)
SAR3.71
SAR1.48B
★★★★★★
Mega Polietilen Köpük Sanayi ve Ticaret Anonim Sirketi (IBSE:MEGAP)
TRY4.75
TRY1.31B
★★★★★☆
E7 Group PJSC (ADX:E7)
AED1.47
AED3B
★★★★★★
Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR)
TRY2.97
TRY3.2B
★★★★★☆
Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR)
AED3.45
AED392.7M
★★★★★★
Dubai Investments PJSC (DFM:DIC)
AED2.89
AED12.25B
★★★★☆☆
Al Dhafra Insurance Company P.S.C (ADX:DHAFRA)
AED4.86
AED486M
★★★★★★
Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC)
AED0.828
AED488.43M
★★★★★★
Tgi Infrastructures (TASE:TGI)
₪2.937
₪218.34M
★★★★★★
Click here to see the full list of 76 stocks from our Middle Eastern Penny Stocks screener.
Here's a peek at a few of the choices from the screener.
Gulf Pharmaceutical Industries P.S.C
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Gulf Pharmaceutical Industries P.S.C., also known as Julphar, manufactures and sells a range of pharmaceutical, cosmetic, and medical products in the UAE, GCC countries, and internationally with a market cap of AED1.68 billion.
Operations: The company's revenue segments include AED732.9 million from Planet and AED864.9 million from Manufacturing.
Market Cap: AED1.68B
Gulf Pharmaceutical Industries P.S.C., known as Julphar, has shown a positive shift in its financial performance, reporting a net income of AED 157.9 million for the first half of 2025 compared to a net loss the previous year. The company's debt is well-managed with operating cash flow covering 31.1% and a reduced debt-to-equity ratio from 117% to 55.9% over five years, indicating improved financial health. Despite low return on equity at 2.4%, Julphar's profitability and stable weekly volatility are promising traits for investors interested in Middle Eastern penny stocks with potential growth prospects amidst operational challenges.
Get an in-depth perspective on Gulf Pharmaceutical Industries P.S.C's performance by reading our balance sheet health report here.
Examine Gulf Pharmaceutical Industries P.S.C's earnings growth report to understand how analysts expect it to perform.
Sinpas Gayrimenkul Yatirim Ortakligi
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Sinpas Gayrimenkul Yatirim Ortakligi, originally established as Sinpas Insaat Anonim Sirketi in 2006 and transformed into a Real Estate Investment Trust (REIT) in 2007, operates in the real estate sector with a market capitalization of TRY17.76 billion.
Operations: The company generates revenue primarily from its Residential Real Estate Developments segment, amounting to TRY12.64 billion.
Market Cap: TRY17.76B
Sinpas Gayrimenkul Yatirim Ortakligi has demonstrated robust financial health, with short-term assets of TRY14.8 billion comfortably covering both its short and long-term liabilities. The company has experienced significant earnings growth, notably an 86.4% increase over the past year, surpassing industry averages. However, a substantial one-off gain of TRY5.3 billion skews recent earnings quality. While its net debt to equity ratio is satisfactorily low at 14.2%, interest coverage remains weak at 2.1 times EBIT, suggesting potential pressure in meeting debt obligations despite stable weekly volatility and reduced debt levels over five years.
Unlock comprehensive insights into our analysis of Sinpas Gayrimenkul Yatirim Ortakligi stock in this financial health report.
Review our historical performance report to gain insights into Sinpas Gayrimenkul Yatirim Ortakligi's track record.
Oil Refineries
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Oil Refineries Ltd. operates in the production and sale of fuel products, intermediate materials, and aromatic products both in Israel and internationally, with a market cap of ₪2.64 billion.
Operations: Currently, there are no reported revenue segments for Oil Refineries Ltd.
Market Cap: ₪2.64B
Oil Refineries Ltd. faces challenges with a net loss of US$37 million in Q2 2025, contrasting with a profit last year. Despite this, its financial structure shows resilience; short-term assets of US$2 billion surpass both short and long-term liabilities. While the dividend yield is high at 10.22%, it isn't supported by earnings, raising sustainability concerns. Debt management has improved over five years, reducing from 127.7% to 75.3%. However, interest payments remain uncovered by EBIT and the company remains unprofitable despite shrinking losses annually by 25.8%. Management's experience offers some stability amid these hurdles.
Dive into the specifics of Oil Refineries here with our thorough balance sheet health report.
Explore historical data to track Oil Refineries' performance over time in our past results report.
Turning Ideas Into Actions
Click here to access our complete index of 76 Middle Eastern Penny Stocks.
Interested In Other Possibilities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ADX:JULPHAR IBSE:SNGYO and TASE:ORL.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
BofA Says 'It Better Be Different This Time,' as Stock Valuations Give Dotcom Bubble Vibes
With U.S. stocks sitting near record highs, Wall Street analysts say one key metric is starting to draw dotcom bubble comparisons. The S&P 500's price-to-book value ratio has climbed to 5.3, a touch above extreme valuations seen in March 2000, right before the dotcom bubble burst, according to Bank of America market strategist Michael Hartnett. Except, "it better be different this time," Hartnett said in a note to clients Thursday. Factors that would suggest the current market cycle is unlike the one in the 1990s—when tech stock valuations ballooned, and subsequently burst in the early 2000s—include bond allocations, the boom in artificial intelligence, currency debasement as well as global rebalancing away from the U.S. to the rest of the world, he said. However, investors partying on hopes the Federal Reserve cuts rates sooner rather than later could drag on the U.S. dollar, as rate cuts would lower the returns and attractiveness of investments in the currency. The firm's Bull & Bear Indicator sits in neutral territory, at a 6.1 on a scale of zero to 10 that measures extreme bearishness to extreme bullishness. "If not different this time, bonds get some love," Hartnett wrote; international stocks would be favored over the S&P 500 too. Investors appear "pumped" with expectations the Fed could soon join the "central bank rate cut party," with valuations being the only hurdle to pushing corporate bonds and stocks higher, he said. Traders are currently pricing in a roughly 87% chance the Fed will cut rates at its next meeting in September, according to the CME Group's FedWatch tool. However, a sharp pivot from Fed's recent policy stance could also give rise to fresh debates on the central bank's independence, and "disruption [equals] debasement," Hartnett said, suggesting a policy disruption could drive the U.S. dollar index below 90 and push investors to seek inflation and currency devaluation hedges in gold, crypto, and emerging markets in the second half of the 2020s. The U.S. dollar index, which measures the relative strength of the dollar compared to other currencies, has declined more than 9% this year, at around 98 as of Friday afternoon. A weaker dollar might prove useful for the Trump administration to see a "'25/'26 boom & bubble," Hartnett said, which he added could be an easy way "to reverse path of US debt & deficit trends." Read the original article on Investopedia Sign in to access your portfolio
Yahoo
35 minutes ago
- Yahoo
S&P 500 Gains & Losses Today: UnitedHealth Stock Climbs After News of Berkshire Stake
Key Takeaways The S&P 500 slipped 0.3% on Friday, Aug. 15, 2025, as a report on consumer sentiment revealed growing concerns about tariff impacts, inflation, and the jobs market. UnitedHealth stock surged as regulatory filings showed that Warren Buffett's Berkshire Hathaway has accumulated a large position in the health insurer. Applied Materials provided an underwhelming outlook for the current quarter, citing macro uncertainty, and shares of the chip equipment maker fell. U.S. stocks logged weekly gains, the major indexes finishing Friday with mixed results heading into the weekend, as the Michigan Consumer Sentiment Index showed declining confidence in the state of the economy for the first time in four months. The S&P 500 declined 0.3% on Friday, snapping a streak of three straight record closing highs. The Nasdaq lost 0.4%, while the Dow held onto a gain of 0.1%. Read today's full daily markets roundup here. UnitedHealth Group (UNH) shares jumped after a regulatory filing showed that Berkshire Hathaway (BRK.A, BRK.B), the firm run by legendary investor Warren Buffett, has increased its stake in the health insurance giant. UnitedHealth and other insurers have been pressured by rising medical costs and changes in government reimbursement rates, which contributed to UnitedHealth's decision to withdraw full-year guidance in May. A surge of 12% made UnitedHealth the S&P 500's top daily performer. Shares of other health insurers also moved higher. Sunrun (RUN), the market share leader in the U.S. residential solar business, beat quarterly sales and profit forecasts. The provider of panel installation and battery storage solutions said it would rely on its experience from past regulatory changes to mitigate the impact from pending changes to clean energy tax credits. Sunrun shares rocketed 33%. Shares of S&P 500 constituents Fist Solar (FSLR) and Enphase Energy (ENPH) shares added 11% and 8.1%, respectively. Moderna (MRNA) advanced 5%, adding to gains posted earlier in the week after Jay Bhattacharya, director of the National Institutes of Health, recognized the potential of the mRNA vaccine technology that underlies Moderna's products. Bhattacharya's view showed more flexibility on mRNA when compared with tougher rhetoric from other health officials tied to the Trump administration, which has moved to cut funding for mRNA-related research. Shares of semiconductor equipment manufacturer Applied Materials (AMAT) tumbled 14%, falling the most of any S&P 500 stock. Although Applied Materials topped sales and profit forecasts for its fiscal fourth quarter, its guidance for the current quarter fell short of forecasts, with macroeconomic uncertainty weighing on its outlook, particularly in China. Shares of fellow chip equipment makers KLA Corp. (KLAC) and Lam Research (LRCX) fell 8.4% and 7.3%, respectively. Paramount Skydance (PSKY) shares lost 4.6%, giving back some of the outsized gains posted earlier in the week as the stock drew comparisons to "meme stocks" that have generated trading frenzies lately. The stock has seen major volatility following the completion of the merger between Skydance Media and Paramount Global. HSBC downgraded Cisco Systems (CSCO) stock to "hold" from "buy" and lowered its price target. Analysts pointed to Cisco's modest revenue growth expectations and the possibility of diminishing momentum as the benefits of restocking cycle that has been boosting the computer networking specialist taper off. Cisco stock slipped 4.5% on Friday. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
35 minutes ago
- Yahoo
Corient Snags $1.5B Dallas-Based Team from Raymond James
You can find original article here Wealthmanagement. Subscribe to our free daily Wealthmanagement newsletter. Corient, the rebranded U.S. wealth management business of CI Financial, announced Thursday the acquisition of Raymond James' firm Messick Peacock & Associates, a Dallas-based team managing $1.54 billion in total assets. The acquisition marks another plus-billion move for Miami-based Corient, which earlier this year acquired a $10.4 billion family office based in New York and, in late 2024, added a $7.9 billion Portland-based wealth manager and trust company. It also comes a few days after Corient's parent firm, CI Financial, officially closed a deal to be taken private by alternative asset manager Mubadala Capital after having previously been listed on the Toronto Stock Exchange. CI announced that $3.4 billion deal in November 2024. Raymond James' asset and wealth management investment banking team served as Messick Peacock's financial advisor in the deal. Messick Peacock was founded in 2015 by Chris Messick and David Peacock as a Raymond James advisory firm. Messick had been with Northwestern Mutual for over 28 years, and Peacock had been with that same firm for over 23 years, according to their LinkedIn profiles. According to its website, the firm has six other employees, including four advisors. 'As ultra-high and high-net-worth individuals, families and businesspeople, our clients have complex lives and financial situations,' Peacock said in a statement. 'Aligning with Corient allows us to broaden and enhance our offering to this discerning group, including those with the most sophisticated and multi-faceted requirements.' Corient, a fee-only wealth manager, has total assets of $197.1 billion, and primarily custodies with Schwab and Fidelity. Since entering the U.S. more than four years ago, it has grown to more than 260 partner firms and over 1,300 employees. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
